Literature DB >> 11249741

Proteomic strategies for biomarker identification: progress and challenges.

E T Fung1, G L Wright, E A Dalmasso.   

Abstract

The simplest definition of a biomarker is a molecule that indicates an alteration in physiology from normal. A more practical definition of a biomarker would require clinical utility of this molecule. In this sense, the biomarker would specifically and sensitively reflect a disease state and could be used for diagnosis as well as for disease monitoring during and following therapy. The need for such biomarkers in all clinical fields is urgent, since the current arsenal of biomarkers is sadly deficient and, in most cases, non-specific. In this review, we discuss strategies that use a proteomics approach to identify novel biomarkers and give examples of recent studies employing these strategies.

Mesh:

Substances:

Year:  2000        PMID: 11249741

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  12 in total

1.  A high productivity/low maintenance approach to high-performance computation for biomedicine: four case studies.

Authors:  Nicholas Carriero; Michael V Osier; Kei-Hoi Cheung; Perry L Miller; Mark Gerstein; Hongyu Zhao; Baolin Wu; Scott Rifkin; Joseph Chang; Heping Zhang; Kevin White; Kenneth Williams; Martin Schultz
Journal:  J Am Med Inform Assoc       Date:  2004-10-18       Impact factor: 4.497

2.  Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS.

Authors:  Qi-bin Song; Wei-guo Hu; Peng Wang; Yi Yao; Hua-zong Zeng
Journal:  Acta Pharmacol Sin       Date:  2011-10-24       Impact factor: 6.150

3.  Profiling of acyl-CoA oxidase-deficient and peroxisome proliferator Wy14,643-treated mouse liver protein by surface-enhanced laser desorption/ionization ProteinChip Biology System.

Authors:  Ruiyin Chu; Weihua Zhang; Hanjo Lim; Anjana V Yeldandi; Chris Herring; Laura Brumfield; Janardan K Reddy; Matthew Davison
Journal:  Gene Expr       Date:  2002

Review 4.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

Review 5.  Clinical use of biomarkers of survival in pulmonary fibrosis.

Authors:  Michiel Thomeer; Jan C Grutters; Wim A Wuyts; Stijn Willems; Maurits G Demedts
Journal:  Respir Res       Date:  2010-06-28

6.  Highly sensitive detection of melanoma based on serum proteomic profiling.

Authors:  Julie Caron; Alain Mangé; Bernard Guillot; Jérôme Solassol
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-14       Impact factor: 4.553

7.  High-throughput proteomics and protein biomarker discovery in an experimental model of inflammatory hyperalgesia: effects of nimesulide.

Authors:  C Gineste; L Ho; P Pompl; M Bianchi; G M Pasinetti
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Discriminating active from latent tuberculosis in patients presenting to community clinics.

Authors:  Gurjinder Sandhu; Francesca Battaglia; Barry K Ely; Dimitrios Athanasakis; Rosario Montoya; Teresa Valencia; Robert H Gilman; Carlton A Evans; Jon S Friedland; Delmiro Fernandez-Reyes; Daniel D Agranoff
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

9.  Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.

Authors:  Fenming Zhang; Chengfu Xu; Longgui Ning; Fengling Hu; Guodong Shan; Hongtan Chen; Ming Yang; Wenguo Chen; Jiekai Yu; Guoqiang Xu
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

10.  Mass spectrometric analysis of cerebrospinal fluid protein for glioma and its clinical application.

Authors:  Jian Liu; Jiekai Yu; Hong Shen; Jianmin Zhang; Weiguo Liu; Zhe Chen; Shuda He; Shu Zheng
Journal:  Contemp Oncol (Pozn)       Date:  2014-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.